Who makes QG101-23-0 capsules?

QG101-23-0 capsules is developed by Amckaus PTY LTD..

What development phase is QG101-23-0 capsules in?

QG101-23-0 capsules is in Phase 1.

Last reviewed 2026-04-19 · How we verify

QG101-23-0 capsules

Amckaus PTY LTD. · Phase 1 active Small molecule

At a glance

Generic name	QG101-23-0 capsules
Sponsor	Amckaus PTY LTD.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

QG101-23-0 capsules CI brief — competitive landscape report
QG101-23-0 capsules updates RSS · CI watch RSS
Amckaus PTY LTD. portfolio CI